Vaccines & Cell/Gene Therapy - From the Quality Perspective - Dec 9, 2020 at 5:00 PM - FREE!
Published
Join the ASQ Raleigh Section for a discussion with Fujifilm Diosynth Biotechnologies and Pfizer on current state of vaccines and cell/gene therapies. Topics Covered:
- Overview of Fujifilm Diosynth Biotechnologies & Pfizer
- Quality/regulatory aspects of manufacturing vaccines and cell/gene therapies
- Unprecedented collaborations to meet global needs
- Redirecting resources - people, raw materials and supplies, manufacturing space, etc.
- Role with COVID-19 vaccine & therapy development & manufacturing
News
Raleigh Section
11/04/2020
Share:
Comments